341 results on '"Wang, Mong-Lien"'
Search Results
2. Modifications of lipid pathways restrict SARS-CoV-2 propagation in human induced pluripotent stem cell-derived 3D airway organoids
3. Circular RNA ZNF800 (hsa_circ_0082096) regulates cancer stem cell properties and tumor growth in colorectal cancer
4. Dual Supramolecular Nanoparticle Vectors Enable CRISPR/Cas9-Mediated Knockin of Retinoschisin 1 Gene-A Potential Nonviral Therapeutic Solution for X-Linked Juvenile Retinoschisis.
5. Is N-acetylcysteine effective in treating patients with coronavirus disease 2019? A meta-analysis
6. Neutrophils Recruited by NKX2‐1 Suppression via Activation of CXCLs/CXCR2 Axis Promote Lung Adenocarcinoma Progression.
7. METTL3-dependent N⁶-methyladenosine RNA modification mediates the atherogenic inflammatory cascades in vascular endothelium
8. Smart healthcare: A prospective future medical approach for COVID-19
9. The Omicron variant wave: Where are we now and what are the prospects?
10. Care for Patients with Stroke During the COVID-19 Pandemic: Physical Therapy and Rehabilitation Suggestions for Preventing Secondary Stroke
11. The study of cancer cell in stromal environment through induced pluripotent stem cell–derived mesenchymal stem cells
12. The Natural History of SARS-CoV-2-Incurred Disease: From Infection to Long COVID
13. Structure-based approaches against COVID-19
14. Neutrophils recruited by NKX2-1 suppression via activation of CXCLs/CXCR2 axis promote lung adenocarcinoma progression
15. A multi-omic investigation of lung adenocarcinoma molecular subtypes
16. Generation of Osimertinib-Resistant Cells from EGFR L858R/T790M Mutant NSCLC Cell Line
17. Hunting coronavirus SARS-CoV-2 (2019-nCoV): from laboratory testing back to basic research
18. Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1
19. Modifications of Lipid Pathways Restrict SARS-CoV-2 Propagation in Human Induced Pluripotent Stem Cell-derived 3D Airway Organoids
20. Judicious use of sodium-glucose cotransporter 2 inhibitors in patients with diabetes on coronavirus-19 pandemic
21. Pharmacological development of the potential adjuvant therapeutic agents against coronavirus disease 2019
22. Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
23. Emerging trends in gene-modified-based chimeric antigen receptor–engineered T-cellular therapy for malignant tumors: The lesson from leukemia to pediatric brain tumors
24. The pharmacological development of direct acting agents for emerging needed therapy against severe acute respiratory syndrome coronavirus-2
25. Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19
26. Novel biosensor platforms for the detection of coronavirus infection and severe acute respiratory syndrome coronavirus 2
27. Use of radiographic features in COVID-19 diagnosis: Challenges and perspectives
28. Hunting severe acute respiratory syndrome coronavirus 2 (2019 novel coronavirus): From laboratory testing back to basic research
29. Genomic analysis and comparative multiple sequences of SARS-CoV2
30. The update of chimeric antigen receptor-T cells therapy in glioblastoma
31. Data from Oncogenic circRNA C190 Promotes Non–Small Cell Lung Cancer via Modulation of the EGFR/ERK Pathway
32. Supplementary Information from Oncogenic circRNA C190 Promotes Non–Small Cell Lung Cancer via Modulation of the EGFR/ERK Pathway
33. Supplementary Data from Oncogenic circRNA C190 Promotes Non–Small Cell Lung Cancer via Modulation of the EGFR/ERK Pathway
34. Supplementary Figure 3 from miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6–Mediated Paracrine Effects in Head and Neck Cancer
35. Supplementary Figure 4 from miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6–Mediated Paracrine Effects in Head and Neck Cancer
36. Data from Oncostatin M Modulates the Mesenchymal–Epithelial Transition of Lung Adenocarcinoma Cells by a Mesenchymal Stem Cell-Mediated Paracrine Effect
37. Supplementary Figure 1 from miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6–Mediated Paracrine Effects in Head and Neck Cancer
38. Supplementary Tables S1-S5 from Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State
39. Supplementary Figure Legends from Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State
40. Supplementary Figures 1-7, Table 1, Methods from Oncostatin M Modulates the Mesenchymal–Epithelial Transition of Lung Adenocarcinoma Cells by a Mesenchymal Stem Cell-Mediated Paracrine Effect
41. Data from Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State
42. Supplementary Figure 2 from miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6–Mediated Paracrine Effects in Head and Neck Cancer
43. Supplementary Tables 1 - 4 from miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6–Mediated Paracrine Effects in Head and Neck Cancer
44. Supplementary Figures S1-S5 from Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State
45. Supplementary Methods and References from Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State
46. Supplementary Methods from miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6–Mediated Paracrine Effects in Head and Neck Cancer
47. Data from Coexpression of Oct4 and Nanog Enhances Malignancy in Lung Adenocarcinoma by Inducing Cancer Stem Cell–Like Properties and Epithelial–Mesenchymal Transdifferentiation
48. Data from miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6–Mediated Paracrine Effects in Head and Neck Cancer
49. Supplementary Figures 1-4, Tables 1-4, Methods from Coexpression of Oct4 and Nanog Enhances Malignancy in Lung Adenocarcinoma by Inducing Cancer Stem Cell–Like Properties and Epithelial–Mesenchymal Transdifferentiation
50. Current developments and therapeutic potentials of exosomes from induced pluripotent stem cells-derived mesenchymal stem cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.